Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E2RA
|
|||
| Former ID |
DNCL003183
|
|||
| Drug Name |
AV-7909
|
|||
| Indication | Anthrax [ICD-11: 1B97; ICD-9: 22] | Phase 2 | [1] | |
| Company |
Emergent BioSolutions
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01770743) A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.